
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.
The CPRD bibliography is updated on a monthly basis (last updated 4 December 2019) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 193 pages)
“When are breast cancer patients at highest risk of venous thromboembolism? A cohort study using English health care data”, Blood, vol. 127, pp. 849-57; quiz 953, 2016.
, “Venous thromboembolism and mortality in breast cancer: cohort study with systematic review and meta-analysis”, BMC Cancer, vol. 17, p. 747, 2017.
, “Variation in the risk of venous thromboembolism in people with colorectal cancer: a population-based cohort study from England”, J Thromb Haemost, vol. 12, pp. 641-9, 2014.
, ,
“Survival of glioma and colorectal cancer patients using tricyclic antidepressants post-diagnosis”, Cancer Causes Control, vol. 23, pp. 1959-64, 2012.
, “Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data”, Br J Cancer, vol. 115, pp. 115-21, 2016.
, “The risk of venous thromboembolism during and after hospitalisation in patients with inflammatory bowel disease activity”, Aliment Pharmacol Ther, vol. 48, pp. 1099-1108, 2018.
, “Risk of vascular disease in adults with diagnosed coeliac disease: a population-based study”, Aliment Pharmacol Ther, vol. 20, pp. 73-9, 2004.
, “Risk of schizophrenia in people with coeliac disease, ulcerative colitis and Crohn's disease: a general population-based study”, Aliment Pharmacol Ther, vol. 23, pp. 71-4, 2006.
, “Risk of hepatocellular carcinoma among individuals with different aetiologies of cirrhosis: a population-based cohort study”, Aliment Pharmacol Ther, vol. 45, pp. 983-990, 2017.
, “Risk of cancer in inflammatory bowel disease treated with azathioprine: a UK population-based case-control study”, Am J Gastroenterol, vol. 105, pp. 1604-9, 2010.
, “The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study”, Aliment Pharmacol Ther, vol. 32, pp. 1343-50, 2010.
, “Proton pump inhibitor prescribing patterns in the UK: a primary care database study”, Pharmacoepidemiol Drug Saf, vol. 25, pp. 1079-87, 2016.
, “Primary biliary cirrhosis does not increase the risk of UTIs following diagnosis compared to other chronic liver diseases?”, Liver Int, vol. 33, pp. 384-8, 2013.
, “The Pattern of Underlying Cause of Death in Patients with Inflammatory Bowel Disease in England: A Record Linkage Study”, J Crohns Colitis, vol. 11, pp. 578-585, 2017.
, “Malignancy and mortality in people with coeliac disease: population based cohort study”, Bmj, vol. 329, pp. 716-9, 2004.
, “Is an internal comparison better than using national data when estimating mortality in longitudinal studies?”, J Epidemiol Community Health, vol. 60, pp. 819-21, 2006.
, “Influence of ursodeoxycholic acid on the mortality and malignancy associated with primary biliary cirrhosis: a population-based cohort study”, Hepatology, vol. 46, pp. 1131-7, 2007.
, “An increased risk of urinary tract infection precedes development of primary biliary cirrhosis”, BMC Gastroenterol, vol. 11, p. 95, 2011.
, “Incidence of venous thromboembolism in patients with cancer - a cohort study using linked United Kingdom databases”, Eur J Cancer, vol. 49, pp. 1404-13, 2013.
, “Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study”, J Invest Dermatol, vol. 132, pp. 2166-70, 2012.
, “Incidence and prevalence of celiac disease and dermatitis herpetiformis in the UK over two decades: population-based study”, Am J Gastroenterol, vol. 109, pp. 757-68, 2014.
, “Incidence and mortality of primary sclerosing cholangitis in the UK: a population-based cohort study”, J Hepatol, vol. 48, pp. 939-44, 2008.
, “Fracture risk in people with primary biliary cirrhosis: a population-based cohort study”, Gastroenterology, vol. 131, pp. 1752-7, 2006.
, “Fracture risk in people with celiac disease: a population-based cohort study”, Gastroenterology, vol. 125, pp. 429-36, 2003.
, “An excess of prior irritable bowel syndrome diagnoses or treatments in Celiac disease: evidence of diagnostic delay”, Scand J Gastroenterol, vol. 48, pp. 801-7, 2013.
, “Excess long-term mortality following non-variceal upper gastrointestinal bleeding: a population-based cohort study”, PLoS Med, vol. 10, p. e1001437, 2013.
, “The epidemiology of haemochromatosis: a population-based study”, Aliment Pharmacol Ther, vol. 29, pp. 183-92, 2009.
, “Defining upper gastrointestinal bleeding from linked primary and secondary care data and the effect on occurrence and 28 day mortality”, BMC Health Serv Res, vol. 12, p. 392, 2012.
, “A comparison of the recording of comorbidity in primary and secondary care by using the Charlson Index to predict short-term and long-term survival in a routine linked data cohort”, BMJ Open, vol. 5, p. e007974, 2015.
, “Comorbidities affect risk of nonvariceal upper gastrointestinal bleeding”, Gastroenterology, vol. 144, pp. 1384-93, 1393.e1-2; quiz e18-9, 2013.
, “Community acquired pneumonia incidence before and after proton pump inhibitor prescription: population based study”, Bmj, vol. 355, p. i5813, 2016.
, “Cause-specific mortality of people with Barrett's esophagus compared with the general population: a population-based cohort study”, Gastroenterology, vol. 144, pp. 1375-83, 1383.e1, 2013.
, “Aspirin and other non-steroidal anti-inflammatory drug use and colorectal cancer survival: a cohort study”, Br J Cancer, vol. 107, pp. 1602-7, 2012.
, “Are IBD patients more likely to have a prior diagnosis of irritable bowel syndrome? Report of a case-control study in the General Practice Research Database”, United European Gastroenterol J, vol. 2, pp. 505-12, 2014.
, “Angiotensin converting enzyme inhibitors and hepatocellular carcinoma incidence in the General Practice Research Database”, Cancer Causes Control, vol. 22, pp. 1743-7, 2011.
, “All-cause mortality in people with cirrhosis compared with the general population: a population-based cohort study”, Liver Int, vol. 32, pp. 79-84, 2012.
, “Adrenergic blockers and the risk for common solid cancers: a case-control study”, Eur J Cancer Prev, vol. 26, pp. 86-93, 2017.
,